'Ecog performance' presentation slideshows

689 views • 49 slides

Gabrielle Sherer Oncology Jennifer Mahnke MS RD CSO LD

Nutritional Status Is Superior to the ECOG Performance Status in Predicting the Dose-Intensity of the GEMOX Chemotherapy Regimen in Patients with Advanced Cancer. Gabrielle Sherer Oncology Jennifer Mahnke MS RD CSO LD. Citation.

330 views • 15 slides

Staging evaluation for NHL

399 views • 12 slides

The Role of Post Forms and End of Life Planning

The Role of Post Forms and End of Life Planning. Tennessee End of Life Partnership Nov 15 th , 2012. Palliative Care Defined.

226 views • 12 slides

SARC023

SARC023. Phase I/II trial of ganetespib , an heat shock protein 90 inhibitor in combination with the mTOR inhibitor sirolimus for patients with unresectable or metastatic malignant peripheral nerve sheath tumor. Principal Investigator: AeRang Kim, MD, PhD

263 views • 11 slides